Procalcitonin: The Right Answer but to Which Question?

Stephen P Bergin^{1

2}, Ephraim L Tsalik^{1

3

4}

Affiliations

¹ Center for Applied Genomics and Precision Medicine.
² Divison of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University.
³ Emergency Medicine Service, Durham Veterans Affairs Medical Center.
⁴ Division of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina.

Comment

Stephen P Bergin et al. Clin Infect Dis. 2017.

. 2017 Jul 15;65(2):191-193.

doi: 10.1093/cid/cix323.

Stephen P Bergin^{1

2}, Ephraim L Tsalik^{1

3

4}

¹ Center for Applied Genomics and Precision Medicine.
² Divison of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University.
³ Emergency Medicine Service, Durham Veterans Affairs Medical Center.
⁴ Division of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina.

No abstract available

Keywords: pneumonia; procalcitonin; respiratory tract infections.

Comment on

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.
Self WH, Balk RA, Grijalva CG, Williams DJ, Zhu Y, Anderson EJ, Waterer GW, Courtney DM, Bramley AM, Trabue C, Fakhran S, Blaschke AJ, Jain S, Edwards KM, Wunderink RG. Self WH, et al. Clin Infect Dis. 2017 Jul 15;65(2):183-190. doi: 10.1093/cid/cix317. Clin Infect Dis. 2017. PMID: 28407054 Free PMC article.